Abstract:The evaluation of inhalation toxicity, drug safety and efficacy assessment, as well as the investigation of complex disease pathomechanisms, are increasingly relying on in vitro lung models. This is due to the progressive shift towards human-based systems for more predictive and translational research. While several cellular models are currently available for the upper airways, modelling the distal alveolar region poses several constraints that make the standardization of reliable alveolar in vitro models relatively difficult. In this work, we present a new and reproducible alveolar in vitro model, that combines a human derived immortalized alveolar epithelial cell line ( AX iAEC) and organ-on-chip technology mimicking the lung alveolar biophysical environment ( AX lung-on-chip). The latter mimics key features of the in vivo alveolar milieu: breathing-like 3D cyclic stretch (10% linear strain, 0.2 Hz frequency) and an ultrathin, porous and elastic membrane. AX iAECs cultured on-chip were characterized for their alveolar epithelial cell markers by gene and protein expression. Cell barrier properties were examined by TER (Transbarrier Electrical Resistance) measurement and tight junction formation. To establish a physiological model for the distal lung, AX iAECs were cultured for long-term at air-liquid interface (ALI) on-chip. To this end, different stages of alveolar damage including inflammation (via exposure to bacterial lipopolysaccharide) and the response to a profibrotic mediator (via exposure to Transforming growth factor β1) were analyzed. In addition, the expression of relevant host cell factors involved in SARS-CoV-2 infection was investigated to evaluate its potential application for COVID-19 studies. This study shows that AX iAECs cultured on the AX lung-on-chip exhibit an enhanced in vivo-like alveolar character which is reflected into: 1) Alveolar type 1 (AT1) and 2 (AT2) cell specific phenotypes, 2) tight barrier formation (with TER above 1,000 Ω cm 2 ) and 3) reproducible long-term preservation of alveolar characteristics in nearly physiological conditions (co-culture, breathing, ALI). To the best of our knowledge, this is the first time that a primary derived alveolar epithelial cell line on-chip representing both AT1 and AT2 characteristics is reported. This distal lung model thereby represents a valuable in vitro tool to study inhalation toxicity, test safety and efficacy of drug compounds and characterization of xenobiotics.

A Biomimetic Human Lung‐on‐a‐Chip with Colorful Display of Microphysiological Breath

A Bionic Controllable Strain Membrane for Cell Stretching at Air–liquid Interface Inspired by Papercutting

A Microfluidic Lung-on-a-chip Based on Biomimetic Hydrogel Membrane

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Reconstituting organ-level lung functions on a chip

Reversed-engineered Human Alveolar Lung-on-a-chip Model.

A bronchiole-on-a-chip and a stretching system for studying human disease model of asthma attack

3D Lung-on-Chip Model Based on Biomimetically Microcurved Culture Membranes

A storm in a teacup -- A biomimetic lung microphysiological system in conjunction with a deep-learning algorithm to monitor lung pathological and inflammatory reactions

A Modular Human Airway Lung‐Chip for Studying the Effect of Breathing‐Mechanics on Airway Epithelial Cell Biology

Physiological and Disease Models of Respiratory System Based on Organ-on-a-Chip Technology

Recapitulating essential pathophysiological characteristics in lung-on-a-chip for disease studies

Airway-On-A-Chip: Designs and Applications for Lung Repair and Disease

Advances of microfluidic lung chips for assessing atmospheric pollutants exposure

Assessment of Air Pollutant PM2.5 Pulmonary Exposure Using a 3D Lung-on-Chip Model

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

A Biomimetic Optical Cardiac Fibrosis-on-a-Chip for High-Throughput Anti-Fibrotic Drug Screening

A Biomimetic Cardiac Fibrosis-on-a-Chip As a Visible Disease Model for Evaluating Mesenchymal Stem Cell-Derived Exosome Therapy.

Collagen Tubular Airway‐on‐Chip for Extended Epithelial Culture and Investigation of Ventilation Dynamics

PLGA Nanofiber/PDMS Microporous Composite Membrane-Sandwiched Microchip for Drug Testing

Graphene Hybrid Anisotropic Structural Color Film for Cardiomyocytes' Monitoring